09.04.2014
- Japanese drug giant Takeda Pharmaceutical has vowed to fight a $6 billion damages award to U.S. plaintiffs who blamed its Actos diabetes drug for their bladder cancer. The company...
21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...
10.03.2014
- In response to an application by U.S. drugmaker Eli Lilly for approval of a New Drug Application (NDA) for its type 2 diabetes treatment empagliflozin, the U.S. Food and Drug...
06.02.2014
- In a move designed to enhance its presence in India, Novartis plans to build a new business center in Hyderabad, India. However, talking to the news agency Reuters. the Swiss...
01.02.2014
- Paris-based pharmaceuticals producer Sanofi has filed a patent infringement suit against U.S. drugmaker Eli Lilly, claiming that its U.S. rival infringed four of its patents for...
07.10.2013
- German healthcare company Merck expects to get a long-term boost from study results in June that showed its main cancer drug Erbitux has an edge over rival product Avastin. Erbitux...
02.09.2013
- Generic drug maker Teva Pharmaceutical Industries said it will stop the development of a depression treatment after a late-stage trial failed to show the drug was more effective...
23.08.2013
- U.S. drugmaker Eli Lilly said it was "deeply concerned" about allegations published in a Chinese newspaper that it spent more than 30 million yuan ($4.90 million) to bribe doctors...
